Completed PHASE4 INTERVENTIONAL NCT00463112

Effect of Diet Plus Sibutramine on Hormonal and Metabolic Features in Overweight and Obese Women With PCOS

Effect of Diet Plus Sibutramine on Hormonal and Metabolic Features in Overweight and Obese Women With PCOS: a Randomized, 24-Week Study

Sponsor: Hippocration General Hospital

Conditions Obesity Polycystic Ovary Syndrome

Interventions Sibutramine

Updated 4 times since 2017 Last updated: Apr 19, 2007 Started: Mar 31, 2004 Completion: Sep 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00463112, this PHASE4 trial focuses on Obesity and Polycystic Ovary Syndrome and remains completed. Sponsored by Hippocration General Hospital, it has been updated 4 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2017 — Jan 2021 [monthly]

Completed PHASE4

First recorded

Mar 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hippocration General Hospital

Data source: Hippocration General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Thessaloniki, Greece